BioWorld

March 6, 2007

View Archived Issues

Lilly Plans Hypnion Takeover, Getting Phase II Insomnia Drug

Less than two months after Phase II success with its insomnia drug, privately held Hypnion Inc. is being taken over by Eli Lilly and Co. for undisclosed terms. (BioWorld Today) Read More

Memory's MEM 1003 Misses In Bipolar Trial; AD Study Ongoing

Read More

VentiRx Raises $26.6M, Plans For Acquisition Of TLR Platform

Read More

Calistoga Secures $21M Series A Investment For p110 Delta Work

Read More

Clinic Roundup

Read More

Other News To Note

Read More